160 related articles for article (PubMed ID: 24636378)
1. Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model.
Wang HI; Aas E; Howell D; Roman E; Patmore R; Jack A; Smith A
Value Health; 2014 Mar; 17(2):205-14. PubMed ID: 24636378
[TBL] [Abstract][Full Text] [Related]
2. A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
[TBL] [Abstract][Full Text] [Related]
3. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
4. Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort.
Wang HI; Smith A; Aas E; Roman E; Crouch S; Burton C; Patmore R
Eur J Health Econ; 2017 Mar; 18(2):255-267. PubMed ID: 26969332
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of decitabine versus best supportive care in the treatment of intermediate- and high-risk myelodysplastic syndromes from a US payer perspective.
Pan F; Peng S; Fleurence R; Linnehan JE; Knopf K; Kim E
Clin Ther; 2010 Dec; 32(14):2444-56. PubMed ID: 21353113
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
Stam WB; O'Sullivan AK; Rijnders B; Lugtenburg E; Span LF; Janssen JJ; Jansen JP
Eur J Haematol; 2008 Dec; 81(6):467-74. PubMed ID: 18754857
[TBL] [Abstract][Full Text] [Related]
7. Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
Ray JA; Boye KS; Yurgin N; Valentine WJ; Roze S; McKendrick J; Tucker DM; Foos V; Palmer AJ
Curr Med Res Opin; 2007 Mar; 23(3):609-22. PubMed ID: 17355742
[TBL] [Abstract][Full Text] [Related]
8. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of allogeneic bone marrow transplantation: a rudimentary model to generate estimates for the timely formulation of clinical policy.
Barr R; Furlong W; Henwood J; Feeny D; Wegener J; Walker I; Brain M
J Clin Oncol; 1996 May; 14(5):1413-20. PubMed ID: 8622054
[TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
[TBL] [Abstract][Full Text] [Related]
11. Clinical management and burden of prostate cancer: a Markov Monte Carlo model.
Sanyal C; Aprikian A; Cury F; Chevalier S; Dragomir A
PLoS One; 2014; 9(12):e113432. PubMed ID: 25474006
[TBL] [Abstract][Full Text] [Related]
12. Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia.
Bosshard R; O'Reilly K; Ralston S; Chadda S; Cork D
Cancer Treat Rev; 2018 Sep; 69():224-232. PubMed ID: 30098484
[TBL] [Abstract][Full Text] [Related]
13. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
14. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.
Juliusson G; Karlsson K; Lazarevic VLj; Wahlin A; Brune M; Antunovic P; Derolf A; Hägglund H; Karbach H; Lehmann S; Möllgård L; Stockelberg D; Hallböök H; Höglund M;
Cancer; 2011 Sep; 117(18):4238-46. PubMed ID: 21387283
[TBL] [Abstract][Full Text] [Related]
17. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.
Hulegårdh E; Nilsson C; Lazarevic V; Garelius H; Antunovic P; Rangert Derolf Å; Möllgård L; Uggla B; Wennström L; Wahlin A; Höglund M; Juliusson G; Stockelberg D; Lehmann S
Am J Hematol; 2015 Mar; 90(3):208-14. PubMed ID: 25421221
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia.
Cressman S; Karsan A; Hogge DE; McPherson E; Bolbocean C; Regier DA; Peacock SJ
Br J Haematol; 2016 Aug; 174(4):526-35. PubMed ID: 27098559
[TBL] [Abstract][Full Text] [Related]
19. [Cost effectiveness in treatment of acute myeloid leukemia].
Nordmann P; Schaffner A; Dazzi H
Schweiz Med Wochenschr; 2000 Dec; 130(51-52):1994-2000. PubMed ID: 11688067
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of endovascular repair, open repair, and conservative management of splenic artery aneurysms.
Hogendoorn W; Lavida A; Hunink MG; Moll FL; Geroulakos G; Muhs BE; Sumpio BE
J Vasc Surg; 2015 Jun; 61(6):1432-40. PubMed ID: 25827968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
